Optimizing Processes, Enhancing Data Integrity and Security

Few, if any, biotechnology and pharmaceutical companies question the growing importance of digital technology in managing information and processes. For CEOs, COOs, and general counsel, digitalization is a matter of when, not if. For quality and production departments, the question is if not now, then when?

In the collective rush to embrace new technologies for managing information, one thing must be addressed: How can companies maintain control and enhance the reliability of computerized data, processes, and procedures while staying compliant. The answer is: Computerized Systems Validation (CSV).

A comprehensive approach: better patient outcomes, processes, and compliance

Conducting the computer system validation process the right way requires a comprehensive approach, one that takes into account the workflow and the complex, ever evolving GMP environment. At GxP-CC, we have the knowledge, experience, and tools for complete validation. We have helped clients around the world clear new thresholds of systems control while staying aligned with standards and regulations. Our focus on better patient outcomes and deep expertise in both the workflows and the evolving regulatory landscape deliver our clients’ success.

What does a successful validation process look like? Increased product and service quality levels, staying compliant with regulations, enhanced information security, continuous improvement, and process automation optimized for the business. It also means a significant drop in IT information system errors, in data integrity issues, and in compliance risk. Even more importantly, a successful validation process lays aside all licensure issues.

See our Latest Insights
View More
Blog
LES implementation readiness checklist
Blog
Embracing digital laboratory transformation with LES
Blog
Navigating the computerized system landscape on the path to laboratory digitalization
Blog
GCP-IWG 2021 Annual Report Reveals Critical Findings in Clinical Trials Quality and Integrity
Blog
AI/ML in Drug Manufacturing: FDA’s discussion paper and PDA’s comments
Blog
Navigating AI Implementation in GxP Environment
Blog
Unleashing the Power of Technology in Clinical Trials: FDA’s Latest Guidance on Electronic Systems, Records and Signatures
Blog
Artificial Intelligence in GxP Regulated Environments: How to Harness its Power While Mitigating Risks
Blog
Highlights des Konzeptpapiers zur Annex 11 Revision
Blog
Highlights of the Concept Paper on the revision of Annex 11
Blog
3 Risks to Your Laboratory Equipment’s Qualification Status
Insight
Better Balance Efficiency, Security for GAMP 5 Category 1 Infrastructure Software
Contact Us
Let’s find the best solution for your compliance needs.
Learn More
Join Our Team
Reach your full potential while making a powerful impact.
Learn More